MarketLens
Sign Up

Kymera's High-Flying Stock Meets Insider Selling

2 months ago
SHARE THIS ON:

Kymera's High-Flying Stock Meets Insider Selling

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News2 months ago

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)

Kymera Therapeutics (KYMR) faces a shareholder investigation by Purcell & Lefkowitz LLP, after potential securities law violations. The probe's scope and catalyst remain unspecified.
Stock News2 months ago

Kymera's CEO Sold $6 Million in Stock After a 170% Run

Kymera CEO sold ~$6M in stock after a 170% run, exercising 50,000 shares at $119 on July 7. The sale reduced direct holdings by 7%.
Stock News2 months ago

Kymera: Building Toward A Defining 2H26 Moment

Kymera Therapeutics is rated Buy ahead of the 2H26 KT-621 Phase 2b readout, a key inflection point. The oral STAT6 degrader targets large atopic dermatitis markets, supported by rapid enrollment and $...

Breaking News

View All →

Top Headlines

View More →
Stock News44 minutes ago

Shell (SHEL) Ascends While Market Falls: Some Facts to Note

Stock News1 hour ago

Chipotle Mexican Grill (CMG) Registers a Bigger Fall Than the Market: Important Facts to Note

Stock News1 hour ago

Amazon (AMZN) Dips More Than Broader Market: What You Should Know

Stock News1 hour ago

Meta plans to launch camera-free smart glasses for fall, The Information reports

Stock News1 hour ago

Microsoft announces quarterly dividend increase